Sol-Gel Technologies Ltd.
NASDAQ:SLGL · NASDAQ Global Market
+$1.19 today
Vol 0.02M · Avg 0.04M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+894.13%
Period High
$97.97
Period Low
$7.01
Latest
$74.46
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Ovid Therapeutics Inc.
NASDAQ:OVID
$307.29M
Zentalis Pharmaceuticals, Inc.
NASDAQ:ZNTL
$261.42M
MacroGenics, Inc.
NASDAQ:MGNX
$257.11M
Oramed Pharmaceuticals Inc.
NASDAQ:ORMP
$157.16M
Coya Therapeutics, Inc.
NASDAQ:COYA
$89.40M
Pliant Therapeutics, Inc.
NASDAQ:PLRX
$71.21M
Tiziana Life Sciences Ltd
NASDAQ:TLSA
$63.97M
Clene Inc.
NASDAQ:CLNN
$61.74M
OKYO Pharma Limited
NASDAQ:OKYO
$60.62M
Anebulo Pharmaceuticals, Inc.
ANEB
$17.23M
What is the latest SLGL filing?
The latest filing shown is SC 13G/A dated Jun 9, 2026.
How many recent filings does SLGL have?
Intrinsic Alpha currently shows 20 recent filings for SLGL.
Explore More
Continue the stock analysis
Jump to another research area for this company.